Partial response of liver metastases treated with abiraterone in castration-resistant prostate cancer: A case report

By Marech Ilaria   Vacca Angelo   Sivestris Nicola   Gnoni Antonio   Lorusso Vito  

Oncology Letters, Vol. 5, Iss. 6, 2013-06 ,pp. : 1877-1880

Spandidos Publications

Access to resources Recommend Favorite

Solitary recurrence of castration-resistant prostate cancer with low or undetectable levels of prostate specific antigen salvaged with local ablative radiation therapy: A case report

By            

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 713-716

Spandidos Publications

Access to resources Recommend Favorite

Molecular mechanisms of castration-resistant prostate cancer progression

By Dutt Smitha S   Gao Allen C  

Future Oncology, Vol. 5, Iss. 9, 2009-11 ,pp. : 1403-1413

Future Medicine

Access to resources Recommend Favorite

The role of enzalutamide in the treatment of castration-resistant prostate cancer

By Rawlinson Alex   Mohammed Aza   Miller Marek   Kunkler Roger  

Future Oncology, Vol. 8, Iss. 9, 2012-09 ,pp. : 1073-1081

Future Medicine

Access to resources Recommend Favorite

Cytotoxic Compounds in the Treatment of Castration-Resistant Prostate Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 10, 2009-12 ,pp. : 1040-1045

Bentham Science Publishers

Access to resources Recommend Favorite